James McCabe, MD
Interventional Cardiology · Seattle, WANPI 1134299787
Payments from drug & device makers
Across 732 payments — averaging $2284.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1.5M
- Medtronic$47K
- Abbott$42K
- Boston Scientific$23K
- W. L. Gore & Associates, Inc.$17K
- Abiomed$16K
- plus $29K from 12 others
What the payments were for
- Consulting fees$156,89054%
- Speaking & faculty fees$51,20018%
- Grants$3,7951%
- Travel & lodging$55,20319%
- Food & beverage$21,6237%
- Education$1950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 401 | $1,497,933 |
| Medtronic(2 entities) | 88 | $47,110 |
| Abbott | 96 | $41,698 |
| Boston Scientific | 39 | $22,696 |
| W. L. Gore & Associates, Inc. | 26 | $17,464 |
| Abiomed | 34 | $15,694 |
| Cardiovascular Systems Inc. | 19 | $14,994 |
| Jenavalve Technology, Inc. | 9 | $4,719 |
| Vascular Solutions, Inc. | 2 | $4,302 |
| Shockwave Medical, Inc | 2 | $2,050 |
| Teleflex LLC | 4 | $1,698 |
| Ancora Heart, Inc. | 4 | $698 |
| Bard Peripheral Vascular, Inc. | 1 | $425 |
| Asahi Intecc USA, Inc. | 2 | $287 |
| Aesculap, Inc. | 1 | $131 |
| Philips North America LLC | 2 | $65 |
| Angiodynamics, Inc. | 1 | $30 |
| Cardiva Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$76,861
- MitraClip$24,800
- COREVALVE EVOLUT R$20,112
- Impella$15,303
- Product in Development$13,124
- Xience V coronary stent system$12,785
- Coronary Orbital Atherectomy System$11,770
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$11,677
- GENERAL - THERAPIES$7,237
- Resolute$7,081
- GENERAL VASCULAR ACCESS$5,228
- Reef HP-APV$4,950
- GUIDEWIRES$4,802
- JenaValve Pericardial TAVR System$4,247
- GENERAL - STRUCTURAL HEART$3,795
- ROTABLATOR$3,500
- GORE CARDIOFORM ASD Occluder$3,315
- GORE CARDIOFORM Septal Occluder$3,287
- Peripheral Orbital Atherectomy System$2,063
- Vascular Lithotripsy$1,500
How this compares
$1,672,011 in reported general payments places this provider in the 95th percentile of 125 interventional cardiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 11 | $66 |
| Furosemide | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Seattle
- Sameer GafoorSeattle$2M
- William LombardiSeattle$1.2M
- Sidakpal PanaichSeattle$1.2M
- Kathleen KearneySeattle$802K
- Ming ZhangSeattle$693K
- Danny DvirSeattle$380K
- Christopher BrownSeattle$328K
- Lorenzo AzzaliniSeattle$310K
- Christine ChungSeattle$272K
- Ravi HiraSeattle$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.